Clinical Trials on Relapsed or Refractory
Total 79102 results
-
Zhujiang HospitalNanfang Hospital of Southern Medical University; The Third Affiliated Hospital... and other collaboratorsTerminatedRelapsed/Refractory Acute Myeloid Leukemia(AML)China
-
Shanghai General Hospital, Shanghai Jiao Tong University...RecruitingRefractory Lymphoma | Refractory Leukemia | Efficacy, Self | T-lymphoblastic Lymphoma | Safety | Relapsed DiseaseChina
-
HutchmedRecruitingRelapsed/Refractory LymphomaChina
-
Arog Pharmaceuticals, Inc.CompletedRelapsed/Refractory Acute Myeloid Leukemia (AML)United States
-
TILT Biotherapeutics Ltd.Merck Sharp & Dohme LLCRecruitingPlatinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Refractory Fallopian Tube Carcinoma | Platinum-Refractory Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma | Platinum-Sensitive Ovarian... and other conditionsUnited States, Finland
-
Taivex Therapeutics CorporationActive, not recruitingAdvanced Refractory Solid TumorsTaiwan
-
Taivex Therapeutics CorporationCompletedAdvanced Refractory Solid TumorsTaiwan
-
Sunshine Lake Pharma Co., Ltd.CompletedAdvanced Refractory Solid TumorsChina
-
National OncoVentureChong Kun Dang PharmaceuticalUnknownAdvanced Refractory Solid TumorsKorea, Republic of
-
Piramal Enterprises LimitedSuspendedAdvanced Refractory Solid TumorsUnited States, India
-
Piramal Enterprises LimitedSuspendedAdvanced Refractory Solid TumorsUnited States, India
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedMalignant Tumors | Refractory TumorsFrance
-
Qilu Pharmaceutical Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
ADC Therapeutics S.A.No longer availableRelapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
-
Samsung Medical CenterCompletedRelapsed and/or Refractory Cutaneous T-cell LymphomaKorea, Republic of
-
LaNova Medicines LimitedWithdrawnRelapsed or Refractory Multiple Myeloma | Other Plasma Cell Diseases
-
Chinese PLA General HospitalUnknownAcute Myeloid Leukemia, in Relapsed or Refractory | Acute Myeloid Leukemia, Elderly, Unfit | Acute Myeloid Leukemia With Positive Minimal Residual DiseaseChina
-
First Affiliated Hospital of Harbin Medical UniversityUnknownCD19-chimeric Antigen Receptor T Cells | Relapsed and/or Refractory Acute Lymphoblastic Leukemia | the Haploidentical Hematopoietic Stem Cell TransplantationChina
-
Madeline FieldsRecruitingDrug Resistant Epilepsy | Refractory Epilepsy | Medically Refractory EpilepsyUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Relapsed Adult ALL | Relapsed CLL | Refractory B-Cell Small Lymphocytic LymphomaUnited States
-
Samsung Medical CenterCompletedRelapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin LymphomaKorea, Republic of
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaUnited States, Turkey, Canada, Netherlands, Australia, Germany, France
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Previously Treated Myelodysplastic Syndromes | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess Blasts in TransformationUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Childhood Ependymoma | Advanced Malignant Solid Neoplasm | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent Non-Hodgkin... and other conditionsUnited States, Puerto Rico
-
iCell Gene TherapeuticsiCAR Bio Therapeutics Ltd. ChinaRecruitingRelapsed/Refractory, Systemic Lupus Erythematosus (SLE)China
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.RecruitingFLT3-positive Relapsed/Refractory Acute Myeloid LeukemiaChina
-
New Epsilon Innovation LimitedActive, not recruitingAdvanced Solid Tumor | Relapsed AML | Refractory AMLHong Kong
-
Hospital Universitario La PazCompletedRelapsed/Refractory Paediatric Acute LeukaemiaSpain
-
Roswell Park Cancer InstituteCelldex TherapeuticsCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Refractory Anemia | Blasts 30 Percent or Less of Bone Marrow Nucleated CellsUnited States
-
Second Affiliated Hospital of Soochow UniversitySciClone PharmaceuticalsRecruitingAdvanced Solid Tumor | Refractory TumorChina
-
National Cancer Institute (NCI)RecruitingMetastatic Solid Tumors | Treatment-Refractory CancersUnited States
-
Samsung Medical CenterCompletedHER2-positive Refractory Advanced CancerKorea, Republic of
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult... and other conditionsUnited States
-
Yale UniversityMerck Sharp & Dohme LLCTerminatedRelapsed Lymphomas | Refractory LymphomasUnited States
-
Rabin Medical CenterUnknown
-
Fred Hutchinson Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Adult Acute Lymphoblastic Leukemia | Refractory Diffuse... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAlisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell LymphomasRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Histiocytic and Dendritic Cell Neoplasm | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Solid Neoplasm | Recurrent... and other conditionsUnited States, Puerto Rico
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Czechia, Sweden, Germany, Belgium, Italy, Canada, France, Netherlands, Poland
-
St. Jude Children's Research HospitalPfizer; IpsenRecruitingRefractory Malignant Solid Neoplasm | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Recurrent Osteosarcoma | Recurrent Peripheral Primitive Neuroectodermal Tumor | Recurrent Rhabdoid Tumor | Recurrent... and other conditionsUnited States, Canada
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult... and other conditionsUnited States
-
University of NebraskaM.D. Anderson Cancer CenterTerminatedCabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple MyelomaMultiple Myeloma | Refractory Multiple Myeloma | Relapsed/Refractory Multiple MyelomaUnited States
-
GI Cell, Inc.RecruitingAdvanced Solid Tumors | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Non-Hodgkin LymphomaKorea, Republic of
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...CompletedRefractory or Recurrent CD30+ Hematologic MalignanciesChina
-
Livzon Pharmaceutical Group Inc.Palm Beach CRO; Keystone Bioanalytical, Inc.CompletedSolid Tumor Refractory to Standard TherapyUnited States
-
Fred Hutchinson Cancer CenterADC TherapeuticsWithdrawnRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Recurrent High... and other conditionsUnited States
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingSolid Tumor, Adult | Refractory TumorUnited States
-
Taiga Biotechnologies, Inc.RecruitingCancer | Refractory Cancer | Tumor, SolidIsrael, United States